dsp-5336,bmf-219,blinatumomab,ziftomenib,revumenib
kura oncology,amgen,syndax pharma,astellas,janssen,biomea fusion,sumitomo dainippon,syndax pharma
['nct04067336', 'ziftomenib', 'leukemia', 'dsp-5336 ', 'leusm', 'blinatumomab', 'revumenib', 'bmf-219', 'syndax', 'kura ', 'biomea fusion', 'janssen', 'sumitomo']
congress| #ash22 dr. rishi kotecha, of , gives an overview of the current clinical trials in development for infant patients with #all, and also highlights the challenges in targeted therapies for this patient subset #allsm #leusm 
A global education platform providing clinical updates on acute lymphoblastic leukemia. #leusm #allsm